Gene expression profile of type II spinal cord decompression sickness

Area of Science:

• Molecular Biology
• Animal Models
• Pathology

Background:

• Spinal cord decompression sickness (SC-DCS) is a serious condition.
• Understanding the molecular mechanisms of SC-DCS is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the molecular pathology of SC-DCS using a rabbit model.
• To identify gene expression changes in the spinal cord following SC-DCS.

Main Methods:

• An experimental, controlled animal study was conducted using male New Zealand white rabbits.
• A gene expression profile chip with 43,803 genes was employed to compare gene expression between SC-DCS and control groups.
• Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) and immunohistochemistry were used to validate selected differentially expressed genes.

Main Results:

• The SC-DCS group exhibited nine upregulated and seventeen downregulated genes compared to controls, primarily related to inflammation, ion channels, cell cycle, material transfer, and apoptosis.
• Parathyroid hormone and tumor necrosis factor alpha (TNF-α) genes were significantly upregulated (P<0.01).
• Acyl-CoA synthetase and voltage-gated channel genes were downregulated (P<0.05), with increased TNF-α expression confirmed in spinal cord tissues.

Conclusions:

• Spinal cord lesions in SC-DCS are associated with multiple gene expression alterations in rabbits.
• Gene expression profiling provides valuable insights into the pathogenesis of decompression sickness.
• Further research is needed to elucidate the full significance of these molecular changes.